Company profile

Sinocelltech Group Ltd.

688520 · SSE

Public Market Listing

688520SSE

SSE primary exchange listing

Live quotes, historical charts, and market capitalization for Sinocelltech Group Ltd. are available on Yahoo Finance.

View quote & market cap on Yahoo Finance ↗

External market data link · No third-party exchange redistribution

Assets

(3 total)
3Total Assets
0Approved
3Phase 3 / Filed
0Phase 1–2 / Early
2Diseases
Quick filter:
Showing 3 of 3 assets
Target & Modality
SCTB14
Phase 3
PD-1 + VEGFSmall molecule
Non-Small Cell Lung Cancer
SCTB41
Phase 3
PD-1 / VEGF / TGF-β receptor II (TGFβRII)Multispecific antibody
Non-Small Cell Lung Cancer
SCTC21C
Phase 3
CD38Biologic — subtype unspecified
Multiple Myeloma

Upcoming events

Research

Unlock the company readout calendar

Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.

Financial reports

Research

Unlock sourced financial history

Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.

Educational data tool. Figures are sourced from company filings and press releases: see each row's filing link. Share price is delayed (~15min) and refreshed periodically, not a real-time feed.